Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice

Jean Philippe Guilloux, Indira Mendez-David, Pehrson Alan, Bruno P. Guiard, Christelle Repérant, Sophie Orvoën, Alain M. Gardier, René Hen, Ebert Bjarke, Silke Miller, Sanchez Connie, Denis J. David

Research output: Contribution to journalArticle

82 Scopus citations

Abstract

Vortioxetine (Lu AA21004) is an investigational novel antidepressant with multimodal activity that functions as a 5-HT 3 , 5-HT 7 and 5-HT 1D receptor antagonist, 5-HT 1B receptor partial agonist, 5-HT 1A receptor agonist and inhibitor of the 5-HT transporter in vitro. Here we explore its anxiolytic and antidepressant potential in adult mice. Vortioxetine was assessed in BalB/cJ@RJ mice using the open-field and forced-swim tests (acute: p.o. 1 h, repeated: daily p.o. 21 days), and in 129S6/SvEvTac mice using the novelty suppressed feeding paradigm (acute: p.o. 1 h, sustained: daily p.o. 14 or 21 days). Fluoxetine and diazepam were controls. Acute and repeated dosing of vortioxetine produced more pronounced anxiolytic- and antidepressant-like activities than fluoxetine. Vortioxetine significantly increased cell proliferation and cell survival and stimulated maturation of immature granule cells in the subgranular zone of the dentate gyrus of the hippocampus after 21 days of treatment. After 14 days, a high dose of vortioxetine increased dendritic length and the number of dendrite intersections, suggesting that vortioxetine accelerates the maturation of immature neurons. Vortioxetine displays an antidepressant and anxiolytic profile following repeated administration associated with increased neurogenesis at several stages. Vortioxetine effects were observed at low levels of 5-HT transporter occupancy, suggesting an alternative mechanism of action to 5-HT reuptake inhibition.

Original languageEnglish
Pages (from-to)147-159
Number of pages13
JournalNeuropharmacology
Volume73
DOIs
StatePublished - 1 Jan 2013

Keywords

  • Antidepressant
  • Anxiolytic
  • Behaviour
  • Mice
  • Multimodal antidepressant
  • Neurogenesis

Fingerprint Dive into the research topics of 'Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice'. Together they form a unique fingerprint.

  • Cite this

    Guilloux, J. P., Mendez-David, I., Alan, P., Guiard, B. P., Repérant, C., Orvoën, S., Gardier, A. M., Hen, R., Bjarke, E., Miller, S., Connie, S., & David, D. J. (2013). Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice. Neuropharmacology, 73, 147-159. https://doi.org/10.1016/j.neuropharm.2013.05.014